Quarter Period Consolidated Statement Of Income

Immuno-Biological Laboratories Co., Ltd. - Filing #7370747

Concept 2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
Quarter period consolidated statement of income
Statement of income
Net sales
2,106,000 JPY
363,410,000 JPY
365,516,000 JPY
JPY
365,516,000 JPY
JPY
1,986,000 JPY
291,179,000 JPY
293,166,000 JPY
293,166,000 JPY
Cost of sales
150,245,000 JPY
119,966,000 JPY
Gross profit (loss)
215,270,000 JPY
173,199,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
200,643,000 JPY
227,761,000 JPY
Operating profit (loss)
-3,079,000 JPY
17,706,000 JPY
14,627,000 JPY
JPY
14,627,000 JPY
JPY
-8,024,000 JPY
-46,537,000 JPY
-54,561,000 JPY
-54,561,000 JPY
Non-operating income
Interest income
47,000 JPY
630,000 JPY
Non-operating income
16,588,000 JPY
16,315,000 JPY
Non-operating expenses
Interest expenses
533,000 JPY
536,000 JPY
Share of loss of entities accounted for using equity method
JPY
90,359,000 JPY
Non-operating expenses
576,000 JPY
91,421,000 JPY
Ordinary profit (loss)
30,639,000 JPY
-129,668,000 JPY
Extraordinary losses
Impairment losses
602,000 JPY
804,000 JPY
Extraordinary losses
769,000 JPY
1,913,000 JPY
Profit (loss) before income taxes
29,869,000 JPY
-131,581,000 JPY
Income taxes - current
3,007,000 JPY
4,586,000 JPY
Income taxes
3,007,000 JPY
4,586,000 JPY
Profit (loss)
26,861,000 JPY
-136,168,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
26,861,000 JPY
-136,168,000 JPY
Comprehensive income
26,861,000 JPY
-136,168,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
26,861,000 JPY
-136,168,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.